KIMBERLY CONTANT: Open Payments
NPI 1225782865 · CONCORD, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 32 payments from 7 companies in 2025. Trend: 2023 $872 · 2024 $316 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $367 |
| Vanda Pharmaceuticals Inc. | 10 | $300 |
| ABBVIE INC. | 5 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $96 |
| Lundbeck LLC | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $54 |
| Alkermes, Inc. | 2 | $49 |
Products named: CAPLYTA, FANAPT, VRAYLAR, COBENFY, REXULTI, Qelbree, ARISTADA.
Industry payments across NH — which companies pay providers there.
